Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

CompletedOBSERVATIONAL
Enrollment

466

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Mycobacterium Infections, Atypical
Trial Locations (59)

Unknown

Site Reference ID/Investigator# 36460, Aichi

Site Reference ID/Investigator# 39122, Aichi

Site Reference ID/Investigator# 36463, Akita

Site Reference ID/Investigator# 36470, Ehime

Site Reference ID/Investigator# 36471, Fukuoka

Site Reference ID/Investigator# 36472, Fukuoka

Site Reference ID/Investigator# 36473, Fukushima

Site Reference ID/Investigator# 36474, Gifu

Site Reference ID/Investigator# 36475, Hiroshima

Site Reference ID/Investigator# 36482, Hyōgo

Site Reference ID/Investigator# 36465, Inzai

Site Reference ID/Investigator# 36483, Ishikawa

Site Reference ID/Investigator# 36484, Kagoshima

Site Reference ID/Investigator# 36485, Kanagawa

Site Reference ID/Investigator# 36486, Kanagawa

Site Reference ID/Investigator# 36487, Kanagawa

Site Reference ID/Investigator# 54466, Kitakyushu

Site Reference ID/Investigator# 54468, Kobe

Site Reference ID/Investigator# 36488, Kochi

Site Reference ID/Investigator# 36513, Kofu

Site Reference ID/Investigator# 39126, Kumamoto

Site Reference ID/Investigator# 36489, Kyoto

Site Reference ID/Investigator# 36493, Kyoto

Site Reference ID/Investigator# 39123, Kyoto

Site Reference ID/Investigator# 54469, Maebashi

Site Reference ID/Investigator# 36494, Miyagi

Site Reference ID/Investigator# 36495, Miyazaki

Site Reference ID/Investigator# 36459, Nagoya

Site Reference ID/Investigator# 36461, Nagoya

Site Reference ID/Investigator# 54465, Nara

Site Reference ID/Investigator# 37145, Obihiro

Site Reference ID/Investigator# 36497, Okayama

Site Reference ID/Investigator# 39125, Okinawa

Site Reference ID/Investigator# 28404, Osaka

Site Reference ID/Investigator# 36492, Osaka

Site Reference ID/Investigator# 36496, Ōita

Site Reference ID/Investigator# 36501, Saitama

Site Reference ID/Investigator# 54464, Saitama

Site Reference ID/Investigator# 36477, Sapporo

Site Reference ID/Investigator# 36478, Sapporo

Site Reference ID/Investigator# 36481, Sapporo

Site Reference ID/Investigator# 36462, Seto

Site Reference ID/Investigator# 36503, Shimane

Site Reference ID/Investigator# 36506, Shimotsuke

Site Reference ID/Investigator# 36504, Shizuoka

Site Reference ID/Investigator# 36505, Shizuoka

Site Reference ID/Investigator# 36499, Takatsuki

Site Reference ID/Investigator# 15101, Tokyo

Site Reference ID/Investigator# 36507, Tokyo

Site Reference ID/Investigator# 36508, Tokyo

Site Reference ID/Investigator# 36509, Tokyo

Site Reference ID/Investigator# 36510, Tokyo

Site Reference ID/Investigator# 42710, Tokyo

Site Reference ID/Investigator# 54470, Tokyo

Site Reference ID/Investigator# 36458, Toyohashi

Site Reference ID/Investigator# 36511, Wakayama

Site Reference ID/Investigator# 37144, Wakayama

Site Reference ID/Investigator# 36512, Yamaguchi

Site Reference ID/Investigator# 39124, Yamanashi

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Taisho Pharmaceutical Co., Ltd.

INDUSTRY

lead

Mylan Inc.

INDUSTRY